- Series
- Part 4 of 12
- Edition
- June 2026
- Reading time
- 33 min
- Sections
- 12
Drawn from CDC STEADI, Bone Health & Osteoporosis Foundation, AAFP, FDA, NIH ClinicalTrials.gov
Executive Summary
A single fall can change everything. One in four Americans age 65 and older falls each year — about 14 million older adults — and falls are the leading cause of both fatal and nonfatal injuries in this age group. For many, that fall is not an isolated event. It is the moment a previously independent life ends and long-term care begins. Falls and fractures are not random accidents. They are the visible consequence of slowly developing underlying conditions: osteoporosis, sarcopenia, frailty, balance disorders, peripheral neuropathy, polypharmacy, and orthostatic hypotension. Each of these conditions builds dependency in its own right. Together, they create the perfect storm that lands so many older adults in a skilled nursing facility. Hip fracture is the most catastrophic outcome. About 319,000 older adults are hospitalized for hip fracture each year in the United States. Within twelve months of that fracture, 17–30% will die. Of the survivors, only one in three returns to their pre-fracture level of function. The rest — roughly two-thirds — live the remainder of their lives with permanent disability, often requiring walking aids, home health support, or full-time nursing care.
This white paper gives patients, family members, and caregivers an honest, current picture of falls, fractures, and the underlying disorders that drive them — from prevention through long-term care planning. It covers:
- Why older adults fall — the conditions behind the event
- Osteoporosis, sarcopenia, and frailty: the silent dependency triad
- Balance disorders, peripheral neuropathy, and orthostatic hypotension
- Polypharmacy and the medications that increase fall risk
- How fall risk and bone health are properly assessed
- Current FDA-approved medications for osteoporosis — including biosimilars and anabolic agents
- Devices, home modifications, and personal emergency response systems
- Clinical trials in sarcopenia, frailty, and senolytic therapy (2026 pipeline)
- The real cost of a fall, a fracture, and the long-term care that follows
- Long-term care planning options — private pay, Medicaid, LTC insurance, and annuities
- The critical importance of acting before the first fall
Understanding Falls and Dependency
The Scale of the Problem
Falls in older adults are not a minor problem — they are the single largest source of injury, disability, and unexpected long-term care need in adults over 65. The numbers are striking:
Falls are now the leading cause of injury death among adults 65 and older. The age-adjusted fall death rate has risen 21% since 2018 and increased 53% over the past decade. Population aging is accelerating, not slowing, this trend.
Why a Fall Changes Everything
A fall in a younger person is usually a passing event. In an older adult, it triggers a cascade that often ends in permanent dependency. Understanding this cascade is the key to understanding why fall prevention is also long-term care planning.
- The injury itself: A hip fracture, vertebral compression fracture, wrist fracture, or head injury can require surgery, weeks of hospitalization, and months of rehabilitation.
- Forced immobility: Bed rest after a fracture causes rapid loss of muscle mass — older adults can lose 1–2% of muscle per day of bed rest. Cardiovascular conditioning declines. Pressure ulcers, pneumonia, blood clots, and delirium become real risks.
- Fear of falling: After a fall, many older adults voluntarily restrict their own activity. The resulting deconditioning makes the next fall more likely — not less. Fear of falling is itself an independent risk factor for future falls.
- Loss of independence: Bathing, dressing, toileting, transferring — the Activities of Daily Living (ADLs) become difficult or impossible. The patient now needs help with the basic tasks of daily life.
- Care transition: Many patients transition from home → hospital → skilled nursing rehabilitation → assisted living or nursing home. About 20% of community-dwelling older adults who fracture a hip move directly into institutional care.
The Underlying Conditions
Falls and fractures do not happen because someone simply 'lost their footing.' They happen because the systems that keep an older adult upright — bone strength, muscle mass, balance, sensation, blood pressure regulation, vision, and judgment — have been quietly failing, often for years. Understanding these underlying conditions is the foundation of effective prevention.
Osteoporosis — The Silent Bone Disease
Osteoporosis is a disease of low bone mass and deteriorated bone structure that makes bones fragile and prone to fracture. It is called 'silent' because there are no symptoms until a fracture occurs.
- 10.2 million Americans aged 50 and older have osteoporosis
- 43.4 million more have low bone mass (osteopenia) — a combined 53.6 million at risk
- Among women age 50 and older, 19.6% have osteoporosis; in men, 4.4%
- More than 80% of osteoporosis patients are women
- Causes approximately 2 million fractures per year in the U.S.
Bone loss accelerates in women after menopause due to falling estrogen, but men experience continued bone loss into older age as well. Other risk factors include advancing age, low body weight, family history, smoking, excessive alcohol, low calcium and vitamin D intake, sedentary lifestyle, and long-term glucocorticoid (steroid) use.
Sarcopenia — Age-Related Muscle Loss
Sarcopenia is the progressive loss of muscle mass, strength, and physical function that comes with aging. After age 50, muscle mass decreases 1–2% per year; muscle strength declines even faster — about 3% per year after age 60. By age 80, the average person has lost approximately 40% of the muscle mass they had at age 20.
- 5–13% of adults aged 60–70 meet criteria for sarcopenia
- 11–50% of adults 80 and older have sarcopenia
- Globally affects more than 50 million people; projected to reach 200 million within 40 years
- Weakened lower-extremity strength directly impairs the ability to recover from a stumble
- Sarcopenia is twice as common as frailty and is the engine of frailty
Sarcopenic obesity — low lean muscle mass combined with high body fat — is a particularly dangerous combination. The patient appears well-nourished or even overweight, masking dangerous underlying muscle weakness. Routine weight checks miss it entirely.
Frailty Syndrome
Frailty is a recognized medical syndrome of reduced physiologic reserve and increased vulnerability to stressors. A frail patient can decompensate dramatically from a relatively minor illness, surgery, or fall that a robust patient would shrug off.
The Fried Phenotype — Five Criteria
- Unintentional weight loss (more than 10 pounds in the past year)
- Self-reported exhaustion
- Weakness (low grip strength)
- Slow walking speed
- Low physical activity level
Zero criteria = robust; one to two = pre-frail; three or more = frail. Among community-dwelling adults 65 and older, 7–10% meet criteria for frailty and 40–50% for pre-frailty. Among octogenarians, 20–40% are frail.
The Clinical Frailty Scale (CFS)
A 9-point scale ranging from very fit (1) to terminally ill (9). Scores of 5–6 (mildly to moderately frail) and 7–8 (severely to very severely frail) strongly predict long-term care placement, hospitalization, and death. Frail patients have 3–5 times higher fall risk than robust patients.
Balance and Vestibular Disorders
The vestibular system — the inner ear's balance organ — degrades with age, often quietly. By age 70, one in three people has had an episode of Benign Paroxysmal Positional Vertigo (BPPV). People with osteoporosis are three times more likely to have BPPV.
- BPPV: Brief episodes of vertigo triggered by head position changes (rolling over in bed, looking up). Caused by displaced inner-ear crystals. Highly treatable in minutes with the Epley maneuver — yet often goes undiagnosed for months or years.
- Vestibular neuritis: Severe acute vertigo lasting days to weeks, often followed by residual chronic imbalance.
- Meniere's disease: Episodes of vertigo, tinnitus, hearing loss, and aural fullness from inner-ear fluid pressure.
- Bilateral vestibulopathy: Loss of vestibular function on both sides — often from ototoxic antibiotics or chronic disease. Produces profound, constant imbalance.
- Cerebellar ataxia: Wide-based, irregular gait from cerebellar disease, stroke, alcohol, or paraneoplastic syndromes.
Gait Disorders
Walking speed naturally decreases about 1% per year after age 60. Slow gait is one of the strongest single predictors of falls, hospitalization, and death in older adults. Several specific gait patterns each carry their own fall risk:
- Parkinsonian gait: Shuffling, festinating, reduced arm swing, and 'freezing' episodes — high fall risk, often with retropulsion (falling backward).
- Antalgic gait: A pain-avoidant pattern from arthritis or recent injury — the patient limps to unload a painful joint.
- Steppage gait: Foot drop from peripheral neuropathy — the foot slaps the ground or the patient lifts the knee high to clear the toe.
- Cautious gait: Slow, short, wide-based steps from fear of falling — further accelerates deconditioning.
Peripheral Neuropathy
Peripheral neuropathy — most often from diabetes, but also from chemotherapy, alcohol, or idiopathic causes — robs the feet of position sense. The patient literally cannot feel where the floor is. Reduced ankle stability and impaired balance on uneven surfaces follow. Diabetic peripheral neuropathy affects about 50% of long-standing diabetics. Combined vestibular and proprioceptive deficits multiply fall risk.
Orthostatic Hypotension
Orthostatic hypotension is defined as a drop in systolic blood pressure of at least 20 mmHg, or diastolic of at least 10 mmHg, within three minutes of standing. The older baroreflex is slower to respond, leaving the brain briefly under-perfused on standing. The result is lightheadedness, presyncope, or syncope — and a fall. Common contributors include dehydration, prolonged bed rest, autonomic neuropathy, antihypertensive medications (especially diuretics and alpha-blockers), and Parkinson's disease. Orthostatic hypotension is highly treatable, yet frequently missed because it requires standing blood pressure measurement — not done at most office visits.
Vision Impairment
Cataracts, glaucoma, macular degeneration, and diabetic retinopathy all reduce the ability to detect hazards in time to avoid them. Multifocal lenses — bifocals and progressives — impair depth perception on stairs and are a recognized fall hazard. Single-focus distance glasses are recommended for walking outside and on stairs. Cataract surgery has been shown to reduce fall rates in older adults.
Polypharmacy and Fall-Risk-Increasing Drugs
Older adults are often on many medications, and certain drug classes are among the most powerful predictors of falls. The medications themselves — not the diseases they treat — cause the falls. Polypharmacy, defined as four or more medications, independently raises fall risk approximately 75% (odds ratio 1.75). Patients on ten or more medications have a 50% higher fall rate and nearly twice the rate of fall-related injury. Among hospitalized older adults who fall, 65–93% are on at least one fall-risk-increasing drug at the time of the fall.
| Drug Class | Examples | Fall Risk Impact |
|---|---|---|
| Benzodiazepines | lorazepam, alprazolam, diazepam, clonazepam | High — short and long-acting equally dangerous; head injury OR 1.76 |
| Z-drugs (sleep) | zolpidem (Ambien), zaleplon, eszopiclone | Very high — head injury OR 3.09 |
| Anticholinergics | diphenhydramine (Benadryl), oxybutynin, tolterodine, muscle relaxants | High — burden score 3 raises fall risk >50% |
| Tricyclic antidepressants | amitriptyline, nortriptyline, doxepin | High — sedation, orthostatic hypotension |
| SSRIs / SNRIs | paroxetine, sertraline, venlafaxine | Moderate to high |
| Antipsychotics | quetiapine, haloperidol, risperidone, olanzapine | High — sedation, parkinsonism, orthostasis |
| Opioids | oxycodone, hydrocodone, tramadol, fentanyl | High — incidence rate ratio 1.73 in LTC |
| Loop diuretics | furosemide (Lasix), torsemide, bumetanide | Moderate — dehydration, orthostatic hypotension |
| Alpha-blockers | doxazosin, terazosin, tamsulosin | Moderate — orthostatic hypotension |
The Post-Hip-Fracture Cascade
Once a hip fracture occurs, a predictable chain of events unfolds:
- Surgery within 24–48 hours (when possible) to minimize complications
- Hospital stay of 5–10 days on average
- Transfer to skilled nursing rehabilitation, often for 20–60 days
- During immobility: pressure ulcers, pneumonia, delirium, blood clots, deconditioning
- Up to 37% die within twelve months of the fracture
- Of survivors, only 31–41% return to pre-fracture function
- 11% become bedridden; 16% require permanent long-term care; 80% need walking aids
- 10–20% sustain another fracture within 12–24 months
Diagnosis and Fall Risk Assessment
Effective fall prevention requires identifying who is at risk — before the first fall, not after. The CDC's STEADI initiative provides a structured, evidence-based framework that any primary care office can implement.
The CDC STEADI Initiative
STEADI — Stopping Elderly Accidents, Deaths & Injuries — is a three-step CDC algorithm: Screen, Assess, Intervene. It incorporates the American Geriatrics Society and British Geriatrics Society Clinical Practice Guideline for Fall Prevention.
Step 1: Screen
Three simple questions identify the majority of high-risk patients:
- Have you fallen in the past year?
- Do you feel unsteady when standing or walking?
- Do you worry about falling?
The CDC also offers a 12-question validated self-assessment called Stay Independent — a score of 4 or higher indicates elevated fall risk.
Step 2: Assess
Patients who screen positive should receive structured gait, balance, and strength testing in the office.
| Assessment | What It Measures | High Risk Threshold |
|---|---|---|
| Timed Up and Go (TUG) | Rise from chair, walk 10 ft, return, sit — timed | ≥ 12 seconds |
| 30-Second Chair Stand | Number of chair rises in 30 seconds | Below age-specific norm |
| 4-Stage Balance Test | Hold four progressively harder stances | Cannot hold tandem stance 10 sec |
| Berg Balance Scale | 14-item standardized balance test (0–56) | ≤ 45 |
| Tinetti POMA | Combined gait + balance assessment (0–28) | ≤ 19 — high risk |
| Orthostatic BP | BP supine → standing at 1 and 3 min | ≥ 20 mmHg systolic drop |
| Medication Review | Identify FRIDs using Beers Criteria | Any FRID on list |
| Vision Screen | Acuity, multifocal lens use | Uncorrected visual impairment |
| Foot Exam | Sensation, deformities, footwear | Reduced monofilament sensation |
Step 3: Intervene
Tailored interventions based on findings: medication adjustment, vitamin D supplementation, vision correction, home modifications, prescribed exercise (Otago Exercise Program or Tai Chi), bone density evaluation, and vestibular rehabilitation when indicated.
Bone Density Testing — DEXA
Dual-Energy X-ray Absorptiometry (DEXA) is the gold standard for measuring bone density. The scan takes about 15 minutes, measures the hip and lumbar spine, and uses about 1/10th the radiation of a chest X-ray.
| T-Score | Diagnosis | Clinical Implication |
|---|---|---|
| ≥ -1.0 | Normal bone density | Continue lifestyle and screening |
| -1.0 to -2.5 | Osteopenia (low bone mass) | Lifestyle interventions, FRAX assessment, possible treatment |
| ≤ -2.5 | Osteoporosis | Treatment indicated |
| ≤ -2.5 + prior fragility fracture | Very high risk osteoporosis | Anabolic agent typically first-line per 2026 guidelines |
Medicare covers DEXA every 24 months for at-risk patients. Typical out-of-pocket cost is $125 to $300. The FDA announced in December 2025 that change in bone mineral density can now be used as a surrogate endpoint in osteoporosis drug trials — expected to accelerate the drug pipeline significantly.
The FRAX Tool
The FRAX fracture risk calculator, developed by the World Health Organization, estimates a patient's 10- year probability of a major osteoporotic fracture or hip fracture. It is free, online, and considers age, sex, weight, height, prior fracture, parental hip fracture, smoking, glucocorticoid use, rheumatoid arthritis, secondary osteoporosis, alcohol use, and (optionally) femoral neck BMD.
- 10-year major osteoporotic fracture risk ≥ 20% — treatment indicated
- 10-year hip fracture risk ≥ 3% — treatment indicated
Vestibular and Orthostatic Testing
When dizziness or imbalance is a primary complaint, additional testing helps identify the specific cause:
- Dix-Hallpike maneuver: Bedside test for posterior canal BPPV — diagnostic and immediately treatable with the Epley maneuver.
- Videonystagmography (VNG): Records eye movements during specific positions and stimuli to identify vestibular dysfunction.
- Video Head Impulse Test (vHIT): Quick assessment of each semicircular canal individually.
- Orthostatic blood pressure: Measure BP and heart rate lying flat, then at 1 minute and 3 minutes of standing.
Functional Assessment for LTC Dependency
From a long-term care perspective, the critical question is not 'did the patient fall?' but 'can they perform Activities of Daily Living independently?' Loss of two or more ADLs is the standard trigger for LTC insurance benefits.
- ADLs: Bathing, dressing, grooming, toileting, transferring, continence, eating.
- IADLs: Medication management, cooking, cleaning, shopping, finances, transportation.
Medications for Bone Health and Fall-Related Conditions (2026)
The medication landscape for osteoporosis has expanded substantially over the past decade. Patients today have access to potent anti-resorptive drugs, bone-building anabolic agents, and now biosimilars that are reducing cost. There is no FDA-approved drug for sarcopenia as of 2026, though several promising candidates are in late-phase trials. Sequential therapy — combining drugs in the correct order — is now the standard for high-risk patients.
Class 1: Bisphosphonates — First-Line Therapy
Bisphosphonates are anti-resorptive drugs — they slow the rate at which bone is broken down. They have been the foundation of osteoporosis treatment for over 25 years and dramatically reduce vertebral, nonvertebral, and hip fracture risk.
| Brand Name | Generic Name | Dosing | Notes |
|---|---|---|---|
| Fosamax | Alendronate | 70 mg oral weekly | Most commonly prescribed; generic available; GI side effects common |
| Actonel | Risedronate | 35 mg weekly or 150 mg monthly oral | Slightly better GI tolerability |
| Boniva | Ibandronate | 150 mg monthly oral or 3 mg IV every 3 months | No proven hip fracture reduction |
| Reclast | Zoledronic acid | 5 mg IV infusion once yearly | Best for poor pill adherence; flu-like reaction common |
Bisphosphonates are generally taken for 3–5 years, then re-evaluated. Long-term use carries rare but serious risks of osteonecrosis of the jaw (ONJ) and atypical femur fracture (AFF). Dental work should be completed before starting therapy when possible.
Class 2: Denosumab (RANKL Inhibitor)
Denosumab is a monoclonal antibody given as a subcutaneous injection every 6 months. It blocks the RANKL pathway that activates bone-resorbing osteoclasts. It reduces vertebral, nonvertebral, and hip fractures and is especially useful in patients with kidney impairment, who cannot take bisphosphonates.
| Brand Name | Generic Name | Approval | Notes |
|---|---|---|---|
| Prolia | Denosumab | 2010 | Reference biologic; ~$3,500–4,000/year |
| Jubbonti | Denosumab-bbdz | March 2024 (FDA — first interchangeable biosimilar) | Lower cost; full Prolia indications |
| Bosaya | Denosumab-kyqq | September 2025 (FDA — interchangeable biosimilar) | Second interchangeable Prolia biosimilar |
Class 3: Selective Estrogen Receptor Modulators (SERMs)
Raloxifene (Evista) — 60 mg oral daily. Reduces vertebral fractures but not hip fractures. Also reduces breast cancer risk in postmenopausal women. Increases the risk of venous thromboembolism (blood clots). Generally reserved for postmenopausal women with low hip fracture risk and elevated breast cancer concerns.
Class 4: Anabolic (Bone-Building) Agents
Unlike bisphosphonates and denosumab, anabolic agents actively build new bone. They are reserved for patients at very high fracture risk and are typically used for a limited duration, followed by an anti-resorptive agent to lock in gains.
| Brand Name | Generic Name | Mechanism | Notes / Cost |
|---|---|---|---|
| Forteo / Bonsity | Teriparatide | PTH analog — daily SC injection | 2-year lifetime limit; ~$41,100/year for Forteo |
| Tymlos | Abaloparatide | PTHrP analog — daily SC injection | 86% vertebral fracture reduction; ~$21,900/year |
| Evenity | Romosozumab | Sclerostin inhibitor — builds bone AND blocks resorption | 12-month course only; ~$21,900; black-box CV warning |
Class 5: Calcium and Vitamin D — The Foundation
No osteoporosis treatment works without adequate calcium and vitamin D. Recommended intake for adults age 50 and older:
- Calcium: 1,000–1,200 mg per day (food first; supplement to fill the gap)
- Vitamin D: 800–1,000 IU per day minimum; many older adults need 2,000+ IU
- Vitamin D level should be checked and supplemented to reach a serum 25-OH-D ≥ 30 ng/mL
Vestibular Medications
- Meclizine (Antivert): Vestibular suppressant for acute vertigo. Use short-term only — it impairs central compensation and increases fall risk with chronic use.
- Betahistine (Serc): Used for Meniere's disease; widely available outside the U.S. but limited domestic availability.
- Diuretics: Hydrochlorothiazide or acetazolamide for Meniere's endolymphatic pressure.
- Intratympanic steroids or gentamicin: For intractable Meniere's disease — performed in an ENT office.
Orthostatic Hypotension Medications
- Fludrocortisone (Florinef): Mineralocorticoid that increases sodium and water retention. Watch for edema and hypokalemia.
- Midodrine (ProAmatine): Alpha-1 agonist vasoconstrictor; taken 3 times daily; supine hypertension is the main concern.
- Droxidopa (Northera): Norepinephrine precursor approved for neurogenic orthostatic hypotension — useful in Parkinson's and pure autonomic failure.
2025–2026 Notable Regulatory Actions
- Bosaya (denosumab-kyqq) approved September 2025 as the second interchangeable Prolia biosimilar
- Jubbonti (denosumab-bbdz) became first interchangeable Prolia biosimilar in March 2024
- FDA accepted change in BMD as a surrogate endpoint for osteoporosis trials — December 2025
- No FDA-approved drug for sarcopenia exists as of 2026 — several candidates in late-phase trials
Devices and Non-Drug Interventions
Drugs reduce fracture risk by strengthening bones, but the most effective fall prevention is multifactorial — combining home modifications, exercise programs, devices, and assistive technology. Many of the highest-impact interventions cost very little.
Personal Emergency Response Systems (PERS)
PERS devices allow an older adult who has fallen and cannot get up to summon help quickly. They reduce the time between fall and treatment — a critical predictor of outcome. Modern systems include in-home base stations, mobile GPS pendants, and smartwatch-based detection.
| Brand / System | Monthly Cost (2026) | Fall Detection | Notes |
|---|---|---|---|
| Life Alert (Help On The Go + GPS) | ~$89.95 + $197 setup | No | Best-known brand; leased equipment |
| Medical Alert (in-home) | $27.95–$47.95 | +$10/mo add-on | Lower cost; multiple brands |
| Lively / GreatCall | $24.99–$34.99 | +$9.99/mo add-on | Now part of Best Buy Health |
| Apple Watch Series 10+ | ~$10–12 cellular (+ device cost) | Yes — built-in for 65+ | Calls 911 if no response in 60 sec |
| Bay Alarm Medical | $24.95–$39.95 | +$10/mo add-on | GPS mobile available |
Apple Watch fall detection has become a major fall response option. Built-in automatic fall detection activates for users 65 and older, with no monthly service required beyond cellular plan. For older adults who already wear a watch, it is often the most acceptable solution.
AI and Sensor-Based Fall Detection (2025–2026)
Research into AI-based fall detection and prediction is advancing rapidly:
- Wearable AI systems combining accelerometers, gyroscopes, and machine learning are detecting 7–8 of every 10 falls in testing
- Smart-home sensors using passive infrared, millimeter-wave radar, and cameras can monitor without wearables
- Predictive AI is starting to detect subtle gait deterioration that precedes falls
- No FDA-cleared pre-fall predictor exists yet, but several systems have detection clearance
- Major consumer health platforms (Amazon, Best Buy Health) are integrating passive monitoring
Ambulatory Aids
Proper fit and proper choice of walking aid dramatically affect both safety and function. A physical or occupational therapist should fit any new device.
- Standard cane: Held on the side opposite the affected limb; cane tip should reach the wrist crease when arm is at side. Lightweight but limited stability.
- Quad cane: Four-point base for greater stability than a standard cane; useful for hemiparesis after stroke.
- Standard walker: Greatest stability but must be lifted with each step — slow and tiring; appropriate for very weak patients.
- Rollator (wheeled walker with seat): Most natural gait, brakes, and a built-in seat for rest. The most widely used device in assisted living and the home.
Home Modifications
The home is where most falls happen. Targeted modifications, often costing a few hundred dollars in total, are among the highest-impact fall prevention interventions ever studied.
- Grab bars in the bathroom — near the toilet and in the shower or tub (single most impactful modification)
- Remove throw rugs and loose floor coverings
- Improve lighting — especially nighttime path from bed to bathroom; consider motion-activated nightlights
- Raised toilet seat, shower chair, and handheld shower head
- Non-slip bath mats and adhesive treads
- Stair handrails on both sides; contrast strips on stair edges
- Clear walking paths; remove low furniture and cords
- Reorganize cabinets so common items don't require step stools
Hip Protectors
External padded shields worn in specialized underwear over the trochanteric area. Evidence is mixed — they reduce hip fracture risk in compliance-controlled studies (especially in nursing homes), but acceptance and consistent wearing in community settings is poor. Most useful for high-risk frail patients in residential care.
Bone Stimulation Devices
Low-intensity pulsed ultrasound (LIPUS) is FDA-cleared for fresh fracture healing. Pulsed Electromagnetic Field (PEMF) devices have limited but supportive evidence in selected osteoporosis patients. Neither is first-line therapy.
Vertebroplasty and Kyphoplasty (for Vertebral Compression Fractures)
For painful vertebral compression fractures that do not respond to conservative management (4–6 weeks of pain control, bracing, and rest), two minimally invasive procedures can dramatically reduce pain:
- Vertebroplasty: Fluoroscopic injection of bone cement (PMMA) into the fractured vertebral body. Provides rapid pain relief but does not restore lost height.
- Kyphoplasty: A balloon is first inflated to restore vertebral height, then bone cement is injected into the created cavity. Better height restoration and slightly lower cement leakage risk.
Hip Fracture Surgery
Hip fracture should be repaired within 24–48 hours when medically feasible — delayed surgery raises mortality and complication rates. About 85% of hip fractures in older adults are now treated with arthroplasty (joint replacement); 15% are repaired with internal fixation.
| Procedure | When Used | Recovery / Outcome |
|---|---|---|
| Cannulated screws / ORIF | Non-displaced or valgus-impacted fractures, younger patients | Bone preserved; higher revision rate |
| Hemiarthroplasty (HA) | Low-demand elderly, multiple comorbidities, limited ambulators | Replaces femoral head only; faster surgery |
| Total Hip Arthroplasty (THA) | Active community ambulators, prior hip arthritis | Best functional outcome; longer surgery, increasingly preferred |
Vestibular Rehabilitation Therapy (VRT)
Therapist-guided gaze stabilization, habituation, and balance exercises that promote central nervous system compensation for vestibular deficits. Highly effective for vestibular neuritis, unilateral vestibulopathy, BPPV residual symptoms, and concussion-related dizziness. Typically 6–12 weeks of in-person therapy followed by a home program.
Evidence-Based Exercise Programs
- Otago Exercise Program (OEP): Individually prescribed home program of lower-limb strength and balance exercises. A 2025 meta-analysis confirmed significant improvements in balance, gait, and lower-limb strength — especially in adults 80+. Best results require at least 24 weeks at 2+ sessions per week. Reduces fear of falling and actual fall rate.
- Tai Chi: Moving for Better Balance: A 48-form simplified Tai Chi program delivered over 24 weeks in community settings. Reduces fall rate, improves balance confidence, and has high adherence because it is enjoyable.
- Combination exercise: Programs combining strength + balance + flexibility + endurance are more effective than any single component alone.
Clinical Trials and Pipeline 2026
After a quiet decade for new fracture-prevention drugs, several major developments are reshaping the pipeline. Sarcopenia drug research is finally producing late-phase candidates. Senolytic research — drugs that clear senescent cells from aging tissue — has expanded from 15 to more than 45 active human trials in five years. And the FDA's December 2025 acceptance of BMD as a surrogate endpoint should accelerate osteoporosis drug development.
Osteoporosis Drug Pipeline
Most pipeline activity in osteoporosis is now centered on biosimilars and on sequential-therapy regimens that combine existing drugs more effectively, rather than entirely new molecules. Two notable themes:
- Additional denosumab biosimilars are entering the market — putting downward pressure on Prolia pricing
- Sequential therapy is now the standard for high-risk patients: anabolic agent first (romosozumab or teriparatide/abaloparatide), followed by a bisphosphonate or denosumab to maintain gains
- Odanacatib (Merck cathepsin K inhibitor) was terminated after Phase 3 due to elevated stroke risk — a cautionary tale that has slowed pipeline activity
- The December 2025 FDA decision allowing BMD change as a surrogate endpoint is expected to revive pipeline activity over the next five years
Sarcopenia Drug Pipeline (No FDA Approval Yet)
There is currently no FDA-approved pharmacologic treatment for sarcopenia. Several candidates are in active trials, with most strategies focused on blocking myostatin or activin pathways that suppress muscle growth. Notable 2026 candidates:
| Drug | Sponsor | Mechanism | Status |
|---|---|---|---|
| Bimagrumab | Novartis / Versanis | Anti-ActRII antibody (blocks myostatin/activin) | Phase 2 with semaglutide combo; Phase 3 planned |
| Apitegromab | Scholar Rock | Targets latent myostatin | Phase 2 + semaglutide/tirzepatide; completed 2025 |
| Trevogrumab + garetosmab | Regeneron | Combined myostatin + activin A inhibition | Phase 2 + semaglutide; primary completion 2026 |
| AMC6156 | Animuscure | Novel oral agent | Phase 1/2 initiated July 2025 |
| Urolithin A (Mitopure) | Amazentis | Mitophagy enhancer | NIH-supported trials; GRAS designation; OTC supplement |
| MYMD-1 | MyMD Pharmaceuticals | TNF-α / NF-κB inhibitor | Phase 2 completed; anti-inflammatory |
| LPCN 1148 | Lipocine | Oral testosterone prodrug | Early-phase development |
Senolytics for Frailty and Healthy Aging
Senolytics are drugs that selectively eliminate senescent cells — old, damaged cells that secrete inflammatory signals and contribute to age-related disease. As of Q1 2026 there are more than 45 active senolytic clinical trials, up from fewer than 15 in 2021.
- Dasatinib + Quercetin (D+Q): The Mayo Clinic/NIH AFFIRM-ABLE trial is investigating impact on physical function in frail older adults across multiple U.S. centers; Phase 2 results expected late 2026.
- Fisetin: Naturally-occurring flavonoid; Mayo Clinic Phase 2 trials enrolling by invitation through 2027. Dosing studied: 20 mg/kg/day for 2 days per month. Targeting inflammation, bone resorption markers, and frailty.
- Navitoclax and other targeted senolytics: Multiple molecules in earlier-phase trials.
No senolytic has yet received FDA approval for a frailty or sarcopenia indication. The field is best understood as promising but still investigational — patients should be cautious about commercial supplement claims that get ahead of the evidence.
AI Fall Prediction Research
- Machine learning systems using wrist accelerometer and gyroscope data show 70–80%+ accuracy in fall prediction in research settings
- Smart-home passive systems using millimeter-wave radar and infrared are advancing toward consumer deployment
- Major consumer platforms (Amazon Halo, Best Buy Health/Lively) are integrating passive monitoring
- No FDA-cleared pre-fall predictive device exists yet, but the regulatory pathway is becoming clearer
The Real Cost of Falls, Fractures, and Care
Falls are the most financially disruptive medical events many families ever encounter — second only to stroke in suddenness, and far more common. A previously independent person can become permanently dependent in a single day, and the costs begin within hours.
Total National and Medicare Costs
| Cost Category | Annual Amount | Notes |
|---|---|---|
| Total U.S. medical cost of older adult falls | ~$50 billion | CDC / NCOA estimate |
| Medicare share of fall costs | ~$29 billion | 67% of all fall costs |
| Medicaid share | ~$9 billion | 18% of all fall costs |
| Private and out-of-pocket | ~$12 billion | ~24% of all fall costs |
| Total osteoporotic fracture cost (Medicare) | $57 billion | BHOF 2024 — projected $95B by 2040 |
| Projected total U.S. fall cost (2030) | >$101 billion | NCOA projection |
| Annual Medicare cost per fracture beneficiary | $21,564 | Incremental cost over non-fracture peers |
Hip Fracture — The Big-Ticket Event
The single hip fracture event drives most of the cost. Recent data from ISPOR 2025 and Summa Health found:
- Mean first-6-month cost per hip fracture patient: $56,051
- Total annual cost per patient (12 months): ~$50,508 — 84% incurred in the first 90 days
- Breakdown: ~59% inpatient hospital, 19% SNF/rehab, 10% outpatient
- Vertebral fracture: 6-month costs average $41,283 when hospitalized
- National annual hip fracture burden: $5.96–17 billion depending on what is included
Long-Term Care Costs (CareScout 2025)
Once a fall causes loss of two or more ADLs, the patient often transitions to long-term care. The 2025 CareScout Cost of Care Survey — the most authoritative source — surveyed more than 25,000 providers nationally.
| Care Setting | Annual Median Cost (2025) | Change YoY |
|---|---|---|
| Home Care — Non-Medical Caregiver (44 hrs/wk) | $80,080 | +3% |
| Assisted Living Community | $74,400 | +5% |
| Memory Care (estimate, AL model) | $97,000–$112,000 | Tracks AL +30–50% |
| Nursing Home — Semi-Private Room | $114,975 | +2% |
| Nursing Home — Private Room | $129,575 | +1% |
| Adult Day Health Care | $24,700 | -5% |
Osteoporosis Drug Annual Costs (Approximate)
| Medication | Approximate Annual Cost | Notes |
|---|---|---|
| Alendronate (generic Fosamax) | $180–360 | Very inexpensive; first-line |
| Zoledronic acid (Reclast) IV | ~$1,200 + administration | Once-yearly infusion |
| Denosumab (Prolia) | $3,500–4,000 | Twice-yearly SC injection; biosimilars lower |
| Jubbonti / Bosaya (biosimilar denosumab) | Lower than brand | Biosimilars introduced 2024–2025 |
| Teriparatide (Forteo) | ~$41,100 | Anabolic; 2-year lifetime limit |
| Abaloparatide (Tymlos) | ~$21,900 | Anabolic; daily SC injection |
| Romosozumab (Evenity) | ~$21,900 | 12-month course; black-box CV warning |
PERS and Home Modification Costs
- Basic in-home PERS button: $27–35 per month
- Mobile GPS PERS with fall detection: $40–55 per month
- Apple Watch (cellular only, after device purchase): ~$10–12 per month
- Grab bar installation (bathroom): $150–400 total
- Walk-in shower conversion: $5,000–15,000
- Stair lift: $3,000–5,000 (straight stairs); $8,000–15,000 (curved)
- Rollator walker: $80–250
Long-Term Care Planning Options
Fall-related dependency rarely lasts a few weeks. For hip fracture survivors, the average post-acute care episode runs 60–100 days in skilled nursing, often followed by months or years of assisted living, home health, or full nursing care. Medicare covers very little of it. Planning before the fall — not after — is what separates families who maintain financial security from those who exhaust assets in 18 months.
What Medicare Covers — And What It Does Not
- Medicare DOES cover: Acute hospital stay, surgery, in-hospital rehabilitation, and up to 100 days of skilled nursing facility care after a qualifying 3-day inpatient hospital stay (days 1–20 in full, days 21–100 with a daily co-pay of about $200 in 2025).
- Medicare DOES NOT cover: Custodial long-term care — meaning routine help with bathing, dressing, toileting, transferring, eating, and supervision. This is the category that consumes most fall recovery costs.
- Medigap (Medicare Supplement) plans: Cover Medicare gaps in acute and post-acute care but do NOT cover custodial care either.
- Medicare Advantage: Some plans include limited supplemental benefits (transportation, home meal delivery, in-home support), but custodial long-term care remains excluded.
Traditional Long-Term Care Insurance
Stand-alone LTC insurance pays a daily or monthly benefit when the policyholder needs help with two or more ADLs or has severe cognitive impairment. Policies are paid for with annual premiums and provide benefits for a defined period (typically 2–6 years) up to a daily benefit (typically $150–$300/day).
- Best purchased in the 50s or early 60s — premiums rise sharply with age and health changes
- Underwriting requires reasonably good health — a recent fall or fracture may disqualify
- Modern policies include inflation protection to keep pace with rising care costs
- Tax-qualified policies offer favorable income tax treatment of benefits
Hybrid Life Insurance with LTC Rider
Permanent life insurance with a long-term care rider has become the dominant product structure since traditional LTC insurance underwent major repricing. Hybrid policies guarantee that the policyholder gets value — either as LTC benefits during life or a death benefit to heirs.
- Single premium, limited-pay, or annual-pay structures available
- LTC benefits typically equal 2–4× the death benefit, accelerated as needed
- Easier underwriting than traditional LTC insurance for many applicants
- Cash value can be surrendered if priorities change
Annuity-Based Long-Term Care Solutions
Under the Pension Protection Act of 2006, qualified annuities can include LTC riders that accelerate annuity value to pay for care — and the LTC withdrawals come out income-tax-free. These products are particularly attractive for asset-rich, income-light retirees with existing annuities or large CD positions.
Medicaid Long-Term Care
Medicaid pays for the majority of U.S. nursing home days but only after a patient has spent down assets to a state-defined threshold (typically $2,000 in countable assets for a single person; protected spousal asset allowance higher).
- Five-year lookback period for asset transfers — gifts within 5 years trigger penalty periods
- Income limits and asset limits vary by state
- Estate recovery after death may claim the home
- Medicaid planning with an elder law attorney can sometimes preserve some assets — but the rules are highly state-specific
Self-Funding from Investments
Some families choose to self-fund long-term care from invested assets. The math is sobering:
- Two years of private nursing home care: ~$259,000
- Five years of assisted living plus home aide combination: ~$300,000–500,000
- Average length of nursing home stay among admittees: 13.7 months
- About 20% of long-term care recipients need care for 5+ years
- A market downturn while drawing down for care can permanently impair the portfolio
Caregiver Burden and Recovery Outcomes
Behind every fall statistic is a family. After a serious fall, family caregivers absorb an enormous burden — physical, emotional, and financial. Understanding the realistic outcomes is essential for planning.
Functional Recovery After Hip Fracture
- Only 31–41% of hip fracture patients return to their pre-fracture level of function
- 50% have permanent functional decline
- 30% lose their personal autonomy
- 40–50% have limitations in at least one ADL at 12 months
- Among community-dwelling patients before the fracture, only 40–44% recover pre-fracture mobility
- 10–20% are institutionalized following the fracture
- About 20% move from home directly into institutional care
- Patients with dementia + hip fracture: only 8% recover pre-fracture ADL function
Caregiver Hours and Burden
- 50% of family caregivers report high burden at 1 month post-surgery
- 36% still report high burden at 3 months
- 26% remain in high-burden status at 1 year
- 56.7% of caregivers in published studies report feeling 'exhausted'
- Caregivers commonly take unpaid leave or reduce work hours, with permanent earnings impact
- Many adult children become hands-on caregivers in addition to full-time jobs
Twelve-Month Mortality
Hip fracture is not a survivable event for everyone. One-year mortality after hip fracture in the United States is 17–30%, with male patients faring worse than females (19.9% vs 15.1%). Mortality risk is 3–4 times that of age-matched peers without hip fracture. Risk factors for non-survival include age 85+, dementia, Charlson comorbidity score >2, and post-operative delirium.
Support Resources for Caregivers
- Eldercare Locator: 1-800-677-1116 — federal helpline connecting families to local services.
- Area Agencies on Aging (AAAs): Local agencies offering home-delivered meals, respite, transportation, and case management.
- National Council on Aging (NCOA): BenefitsCheckUp tool to identify benefit programs the senior may qualify for.
- Family Caregiver Alliance: Education, support groups, and care planning tools (caregiver.org).
- National Falls Prevention Resource Center: Evidence-based program directory and educational materials (ncoa.org/falls-prevention).
- Medicare Home Health Compare: Quality ratings for home health agencies.
Key Organizations and Resources
Medical and Research Organizations
- Centers for Disease Control STEADI: cdc.gov/steadi — clinical guidance, screening tools, patient education for fall prevention.
- Bone Health & Osteoporosis Foundation: bonehealthandosteoporosis.org — patient and clinician resources, advocacy.
- National Institute on Aging (NIA): nia.nih.gov — research and patient education on aging, falls, frailty.
- American Geriatrics Society: americangeriatrics.org — Beers Criteria, clinical practice guidelines.
- American Academy of Orthopaedic Surgeons (AAOS): aaos.org — patient education on hip fracture, joint replacement, vertebral fractures.
- Vestibular Disorders Association: vestibular.org — patient education and clinician directory.
- International Osteoporosis Foundation: osteoporosis.foundation — global resources and statistics.
Government and Long-Term Care Resources
- Medicare.gov: Coverage details, plan finder, care comparison tools.
- Eldercare Locator: eldercare.acl.gov or 1-800-677-1116.
- National Council on Aging (NCOA): ncoa.org — falls prevention programs, BenefitsCheckUp.
- Administration for Community Living (ACL): acl.gov — federal coordination of aging services.
- State Health Insurance Assistance Programs (SHIP): Free Medicare counseling in every state.
Evidence-Based Fall Prevention Programs
- Otago Exercise Program — individual home program by PT prescription
- Tai Chi: Moving for Better Balance — community group classes
- A Matter of Balance — workshop series addressing fear of falling
- Stepping On — 7-week community-based fall prevention workshop
- Stay Active and Independent for Life (SAIL) — evidence-based exercise program
Next Steps for Patients and Families
Whether you are an active 65-year-old without symptoms, the family member of someone who recently fell, or a caregiver navigating skilled nursing rehabilitation, the same core actions apply — just on different timelines.
Before the First Fall
- Get a bone density (DEXA) scan if you are a woman 65+, a man 70+, or have any major risk factor
- Ask your physician for a STEADI screening at every annual visit
- Get a medication review — specifically ask about the Beers Criteria fall-risk drugs
- Have your vision checked annually and consider cataract surgery if indicated
- Start an evidence-based exercise program (Otago, Tai Chi)
- Install grab bars and improve lighting — before you need them
- Investigate long-term care insurance or hybrid options NOW, while you are insurable
- Make sure powers of attorney for healthcare and finances are in place
After a Fall or Near-Fall
- Be honest with your physician — many seniors hide falls out of fear of losing independence
- Get a full fall risk assessment — TUG, balance testing, orthostatic BP
- Request a comprehensive medication review by a pharmacist or geriatrician
- Ask about physical therapy referral for balance and strength
- Get a DEXA scan if not done recently
- Consider a PERS device — Apple Watch, Lively, or traditional medical alert
- Begin home modifications immediately — grab bars, lighting, remove hazards
After a Hip Fracture or Major Fall Injury
- Insist on physical therapy starting day 1 post-op — early mobilization prevents complications
- Ask about delirium prevention protocols in the hospital
- Confirm bone-protective therapy is started before discharge (most patients leave without it)
- Plan for the post-acute period — most patients underestimate how long they will need help
- Review long-term care funding options with a financial advisor specializing in this area
- Engage care management — Medicare-covered home health and care coordination resources
- Address caregiver burnout proactively — schedule respite, accept help, use AAA resources
Sources & References
- Centers for Disease Control and Prevention. Older Adult Falls Data. cdc.gov/falls/data-research
- Centers for Disease Control and Prevention. STEADI — Stopping Elderly Accidents, Deaths & Injuries. cdc.gov/steadi
- CDC NCHS Data Brief #532. Fall-Related Deaths Among Adults Aged 65 and Older. June 2025.
- CDC NCHS Data Brief. Osteoporosis and Low Bone Mass in Older Adults: United States, 2017–2018. cdc.gov/nchs/products/databriefs/db405.htm
- National Council on Aging. Falls Prevention Facts. ncoa.org/article/get-the-facts-on-falls-prevention
- American Academy of Family Physicians. Hip Fractures in Older Adults. AAFP 2022.
- Bone Health and Osteoporosis Foundation. Diagnosis and Bone Density Testing. bonehealthandosteoporosis.org
- International Osteoporosis Foundation. Epidemiology of Osteoporotic Fractures. osteoporosis.foundation
- American Geriatrics Society. 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use.
- CareScout (formerly Genworth). 2025 Cost of Care Survey. carescout.com
- Bone Health and Osteoporosis Foundation. Medicare TEAM Comment Letter on Fracture Costs. June 2024.
- FDA. First Interchangeable Biosimilars to Prolia (denosumab) Approved — Jubbonti and Wyost. March 2024.
- FDA. Bosaya (denosumab-kyqq) Approval. September 2025.
- Medscape. Sequential Osteoporosis Drug Therapy Guidelines 2026. medscape.com
- ISPOR 2025. Fracture Incidence and Costs in U.S. Post-Fracture Patients — Commercial Claims Analysis.
- Frontiers in Public Health 2025. Otago Exercise Program Meta-Analysis. frontiersin.org
- NIH ClinicalTrials.gov. Multiple sarcopenia and senolytic trial registrations accessed June 2026. clinicaltrials.gov
- Scholar Rock. Apitegromab Phase 2 Clinical Trial Results. 2025.
- PMC. Myostatin Inhibitors and Sarcopenia — Review 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12719006
- Mayo Clinic. AFFIRM-ABLE Trial — Dasatinib + Quercetin Senolytic Therapy in Frailty.
- PMC. Fisetin Clinical Trials for Frail Elderly Syndrome. NCT03675724, NCT03430037.
- Vestibular Disorders Association. Balance and Falls Resource. vestibular.org
- SafeHome.org. Medical Alert and PERS Comparison 2026. safehome.org
- American Academy of Orthopaedic Surgeons. Hip Fracture Surgery Outcomes 2025.
- National Safety Council. Older Adult Falls — Injury Facts 2025. injuryfacts.nsc.org
Disclaimer
This white paper is provided for educational purposes only. It does not constitute medical advice, financial advice, or legal advice. Information about clinical trials, medications, and costs is current as of June 2026 and may change. Consult qualified medical, legal, and financial professionals for guidance specific to your situation. Medicaid rules vary significantly by state.
Download the Falls and Fractures White Paper
Get the Falls and Fractures white paper as a free, print-ready PDF — one condition, covered end to end: what it is, how it progresses, the care it typically requires, what that care costs, and the planning questions families are usually glad they asked early. Fill out the short form and your download link appears right away. Want all twelve conditions in one volume? Request the complete white paper collection.
Stay Informed on Clinical Research
New clinical trials for Falls and Fractures open regularly. Get a brief, no-spam monthly email summarizing newly registered trials, notable research findings, and what they might mean for families managing this condition.